Results 211 to 220 of about 112,672 (261)

Assessment of Indications for Percutaneous Coronary Intervention: A Multicenter Analysis after the Diagnosis of Chronic Coronary Syndrome. [PDF]

Dtsch Arztebl Int
Zeymer U, Kelsch N, Werdan K, Braun JP, Winklmair C, Lauer B, Thiele H, Riemer T, Weber M.   +8 more
europepmc   +1 more source

Outcome evaluation of percutaneous coronary intervention vs medical therapy alone in patients with chronic coronary syndrome. [PDF]

J Food Drug Anal
Chang HY, Fang HY, Huang MS, Chen YZ, Chen DY, Lai EC, Wang JD, Li YH, Ku LE.   +8 more
europepmc   +1 more source

Biolimus- versus sirolimus-eluting stents in percutaneous coronary intervention: a comprehensive systematic review and meta-analysis of randomised controlled trials. [PDF]

AsiaIntervention
Suruagy-Motta RFO, Dexheimer da Silva L, Rezende Neves G, Farias CA, Galvão de Oliveira Oldra L, Machado Gomes de Sousa PA, Damiani Bertoli E, Martins Filho E, Cox-Alomar P, Pileggi B, Craveiro de Melo P, de Andrade Nunes D, Azzalini L, Kumar S.   +13 more
europepmc   +1 more source

Appropriateness of Percutaneous Coronary Intervention [PDF]

JAMA - Journal of the American Medical Association, 2011
Despite the widespread use of percutaneous coronary intervention (PCI), the appropriateness of these procedures in contemporary practice is unknown.To assess the appropriateness of PCI in the United States.Multicenter, prospective study of patients within the National Cardiovascular Data Registry undergoing PCI between July 1, 2009, and September 30 ...
Manesh Patel, Frederick A Masoudi
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Percutaneous Intervention of Coronary Aneurysm

Cardiovascular Revascularization Medicine, 2020
The coronary artery aneurysm (CAA) is not a frequent condition in the catheterization laboratory. The management is uncertain. Most of the cases, the treatment is surgical with good results. In smaller aneurysm, the use of covered stents is an alternative. This is an anterograde approach CTO (chronic total occlusion) case of a middle segment RCA (right
Pablo, Antileo, Christian, Dauvergne, Manuel, Méndez, Marcio, Alvarado, Óscar, Sepúlveda, Rodrigo, Monsalve, Jorge, Sandoval   +6 more
openaire   +2 more sources

Percutaneous coronary intervention

Medicine, 2002
Percutaneous coronary intervention (PCI) is the dominant method for mechanically improving myocardial perfusion in the treatment of coronary artery disease. The procedure is performed via a small intra-arterial sheath and usually involves a single overnight stay in hospital. Day-case treatment is not infrequent. A balloon is used to dilate the coronary
openaire   +2 more sources

Cangrelor in percutaneous coronary intervention

Expert Review of Clinical Pharmacology, 2009
Cangrelor is a novel, intravenous P2Y12 receptor antagonist in development for use in percutaneous coronary intervention. Currently in Phase III testing, the reversible platelet inhibitor provides several inherent advantages over other P2Y12 receptor antagonists in this setting for the prevention of adverse cardiac events.
Julie H, Oestreich, Steven R, Steinhubl
openaire   +2 more sources

Coronary ischemia and percutaneous intervention

Cardiovascular Pathology, 2010
The interventional treatment of ischemia is a complex issue grounded on an understanding of basic pathophysiology, but translated and implemented in practice by extensive clinical trial data representing patients with a spectrum of ischemia-causing clinical syndromes and anatomical variations of coronary artery disease (CAD).
Paul A, Hudson, Michael S, Kim, John D, Carroll   +2 more
openaire   +2 more sources